Larvol Delta - Aptinyx-Recommences-Patient-Recruitment-in-Phase-2-Study-of-NYX2925-in-Patients-with-Fibromyalgia

NYX-2925 - Aptinyx

https://www.businesswire.com/news/home/20200928005184/en/Aptinyx-Recommences-Patient-Recruitment-in-Phase-2-Study-of-NYX-2925-in-Patients-with-Fibromyalgia

Sep 28, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next